Marek Trneny

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study

Nibedita Bandyopadhyay, Martin Dreyling, Mathias Witzens-Harig, 2016, The Lancet.

MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia.

Jiri Zavadil, Pavel Burda, Vojtech Kulvait, 2011, Blood.